Marginal structural cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort

Mohammad Ehsanul Karim, Paul Gustafson, John Petkau, Yinshan Zhao, Afsaneh Shirani, Elaine Kingwell, Charity Evans, Mia Van Der Kop, Joel Oger, Helen Tremlett

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Longitudinal observational data are required to assess the association between exposure to β-interferon medications and disease progression among relapsing-remitting multiple sclerosis (MS) patients in the real-world clinical practice setting. Marginal structural Cox models (MSCMs) can provide distinct advantages over traditional approaches by allowing adjustment for time-varying confounders such as MS relapses, as well as baseline characteristics, through the use of inverse probability weighting. We assessed the suitability of MSCMs to analyze data from a large cohort of 1,697 relapsing-remitting MS patients in British Columbia, Canada (1995-2008). In the context of this observational study, which spanned more than a decade and involved patients with a chronic yet fluctuating disease, the recently proposed normalized stabilized weights were found to be the most appropriate choice of weights. Using this model, no association between β-interferon exposure and the hazard of disability progression was found (hazard ratio = 1.36, 95% confidence interval: 0.95, 1.94). For sensitivity analyses, truncated normalized unstabilized weights were used in additional MSCMs and to construct inverse probability weight-adjusted survival curves; the findings did not change. Additionally, qualitatively similar conclusions from approximation approaches to the weighted Cox model (i.e., MSCM) extend confidence in the findings.

Original languageEnglish (US)
Pages (from-to)160-171
Number of pages12
JournalAmerican Journal of Epidemiology
Volume180
Issue number2
DOIs
StatePublished - Jul 15 2014

Fingerprint

Structural Models
Proportional Hazards Models
Interferons
Multiple Sclerosis
Disease Progression
Weights and Measures
Relapsing-Remitting Multiple Sclerosis
British Columbia
Canada
Observational Studies
Confidence Intervals
Recurrence
Survival

Keywords

  • bias (epidemiology)
  • causality
  • confounding factors (epidemiology)
  • epidemiologic methods
  • inverse probability weighting
  • marginal structural Cox model
  • multiple sclerosis
  • survival analysis

ASJC Scopus subject areas

  • Epidemiology

Cite this

Marginal structural cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort. / Karim, Mohammad Ehsanul; Gustafson, Paul; Petkau, John; Zhao, Yinshan; Shirani, Afsaneh; Kingwell, Elaine; Evans, Charity; Van Der Kop, Mia; Oger, Joel; Tremlett, Helen.

In: American Journal of Epidemiology, Vol. 180, No. 2, 15.07.2014, p. 160-171.

Research output: Contribution to journalArticle

Karim, Mohammad Ehsanul ; Gustafson, Paul ; Petkau, John ; Zhao, Yinshan ; Shirani, Afsaneh ; Kingwell, Elaine ; Evans, Charity ; Van Der Kop, Mia ; Oger, Joel ; Tremlett, Helen. / Marginal structural cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort. In: American Journal of Epidemiology. 2014 ; Vol. 180, No. 2. pp. 160-171.
@article{1dabd265e6544c5686d178ec53cdc169,
title = "Marginal structural cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort",
abstract = "Longitudinal observational data are required to assess the association between exposure to β-interferon medications and disease progression among relapsing-remitting multiple sclerosis (MS) patients in the real-world clinical practice setting. Marginal structural Cox models (MSCMs) can provide distinct advantages over traditional approaches by allowing adjustment for time-varying confounders such as MS relapses, as well as baseline characteristics, through the use of inverse probability weighting. We assessed the suitability of MSCMs to analyze data from a large cohort of 1,697 relapsing-remitting MS patients in British Columbia, Canada (1995-2008). In the context of this observational study, which spanned more than a decade and involved patients with a chronic yet fluctuating disease, the recently proposed normalized stabilized weights were found to be the most appropriate choice of weights. Using this model, no association between β-interferon exposure and the hazard of disability progression was found (hazard ratio = 1.36, 95{\%} confidence interval: 0.95, 1.94). For sensitivity analyses, truncated normalized unstabilized weights were used in additional MSCMs and to construct inverse probability weight-adjusted survival curves; the findings did not change. Additionally, qualitatively similar conclusions from approximation approaches to the weighted Cox model (i.e., MSCM) extend confidence in the findings.",
keywords = "bias (epidemiology), causality, confounding factors (epidemiology), epidemiologic methods, inverse probability weighting, marginal structural Cox model, multiple sclerosis, survival analysis",
author = "Karim, {Mohammad Ehsanul} and Paul Gustafson and John Petkau and Yinshan Zhao and Afsaneh Shirani and Elaine Kingwell and Charity Evans and {Van Der Kop}, Mia and Joel Oger and Helen Tremlett",
year = "2014",
month = "7",
day = "15",
doi = "10.1093/aje/kwu125",
language = "English (US)",
volume = "180",
pages = "160--171",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Marginal structural cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort

AU - Karim, Mohammad Ehsanul

AU - Gustafson, Paul

AU - Petkau, John

AU - Zhao, Yinshan

AU - Shirani, Afsaneh

AU - Kingwell, Elaine

AU - Evans, Charity

AU - Van Der Kop, Mia

AU - Oger, Joel

AU - Tremlett, Helen

PY - 2014/7/15

Y1 - 2014/7/15

N2 - Longitudinal observational data are required to assess the association between exposure to β-interferon medications and disease progression among relapsing-remitting multiple sclerosis (MS) patients in the real-world clinical practice setting. Marginal structural Cox models (MSCMs) can provide distinct advantages over traditional approaches by allowing adjustment for time-varying confounders such as MS relapses, as well as baseline characteristics, through the use of inverse probability weighting. We assessed the suitability of MSCMs to analyze data from a large cohort of 1,697 relapsing-remitting MS patients in British Columbia, Canada (1995-2008). In the context of this observational study, which spanned more than a decade and involved patients with a chronic yet fluctuating disease, the recently proposed normalized stabilized weights were found to be the most appropriate choice of weights. Using this model, no association between β-interferon exposure and the hazard of disability progression was found (hazard ratio = 1.36, 95% confidence interval: 0.95, 1.94). For sensitivity analyses, truncated normalized unstabilized weights were used in additional MSCMs and to construct inverse probability weight-adjusted survival curves; the findings did not change. Additionally, qualitatively similar conclusions from approximation approaches to the weighted Cox model (i.e., MSCM) extend confidence in the findings.

AB - Longitudinal observational data are required to assess the association between exposure to β-interferon medications and disease progression among relapsing-remitting multiple sclerosis (MS) patients in the real-world clinical practice setting. Marginal structural Cox models (MSCMs) can provide distinct advantages over traditional approaches by allowing adjustment for time-varying confounders such as MS relapses, as well as baseline characteristics, through the use of inverse probability weighting. We assessed the suitability of MSCMs to analyze data from a large cohort of 1,697 relapsing-remitting MS patients in British Columbia, Canada (1995-2008). In the context of this observational study, which spanned more than a decade and involved patients with a chronic yet fluctuating disease, the recently proposed normalized stabilized weights were found to be the most appropriate choice of weights. Using this model, no association between β-interferon exposure and the hazard of disability progression was found (hazard ratio = 1.36, 95% confidence interval: 0.95, 1.94). For sensitivity analyses, truncated normalized unstabilized weights were used in additional MSCMs and to construct inverse probability weight-adjusted survival curves; the findings did not change. Additionally, qualitatively similar conclusions from approximation approaches to the weighted Cox model (i.e., MSCM) extend confidence in the findings.

KW - bias (epidemiology)

KW - causality

KW - confounding factors (epidemiology)

KW - epidemiologic methods

KW - inverse probability weighting

KW - marginal structural Cox model

KW - multiple sclerosis

KW - survival analysis

UR - http://www.scopus.com/inward/record.url?scp=84904018610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904018610&partnerID=8YFLogxK

U2 - 10.1093/aje/kwu125

DO - 10.1093/aje/kwu125

M3 - Article

C2 - 24939980

AN - SCOPUS:84904018610

VL - 180

SP - 160

EP - 171

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 2

ER -